Ocular Therapeutix (OCUL) 10-K2017 FY Annual report

Filed: 8 Mar 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abridged, ACA, accident, adapt, advice, Advisor, aggressive, al, allegedly, Allied, alongside, Angel, angle, anniversary, Antony, belted, bidding, bill, billed, bipartisan, Brexit, Brian, bright, broadening, bulk, Cadillac, captioned, Caraker, CCC, CEO, cited, clause, Commonwealth, companion, consummated, consummation, Corwin, counsel, County, cousin, CSR, declaratory, dental, DEXTENXA, DEXTENXZA, DEXTNZA, DEXYCU, dismissal, dismissed, disproportionate, docket, durability, Dutch, duty, Dylan, EC, electorate, electrical, enrichment, Envisia, equitable, excise, fiber, fiduciary, flat, Gallagher, grown, House, inappropriate, incorrectly, indefinitely, inquiry, Inspector, interior, intraday, Jersey, Jonathan, Kelly, Kim, Kingdom, leverage, Lisbon, lot, Madera, magistrate, mandate, Mattessich, misleading, mismanagement, motion, neutrality, nominal, offshore, OMB, owner, particulate, passed, passing, PCAOB, peripheral, plaintiff, preformed, prejudice, premised, principle, provisional, purported, referendum, regime, regrow, reorganized, repatriated, resignation, resigned, revoked, Robert, Robinson, rulemaking, runway, Sawney, sclera, Senate, shallowing, Shawna, shortage, skinny, stalled, subpoena, Suffolk, sunset, SV, Talamo, taxation, TCJA, telecommunication, tenant, territory, terrorism, Terry, thereunder, top, Treaty, undermine, unjust, unspecified, unused, urge, vacated, Vice, vigorously, vulnerable, war, workforce, wrongdoing

Removed: Affordability, anticipation, calling, changeover, clean, combine, computing, contractually, conversion, convert, depot, Education, Fovista, guideline, Helsinki, immunomodulator, improperly, Ophthotech, PPACA, prohibiting, promissory, refund, retroactively, sicca, simple, split, suppressed, unamortized, whichever

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated OCUL transcripts

OCUL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Ocular Therapeutix, Inc. (the “Company”) for the period ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Donald Notman, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: March 8, 2018	By:	/s/ Donald Notman
		Donald Notman
		Chief Financial Officer
		(Principal Financial and Accounting Officer)